These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16163203)

  • 1. Adult ALL: where are we and where are we going?
    Larson RA
    Clin Adv Hematol Oncol; 2004 Jun; 2(6):342-4. PubMed ID: 16163203
    [No Abstract]   [Full Text] [Related]  

  • 2. Tyrosine kinase inhibitors in BCR-ABL positive acute lymphoblastic leukemia.
    Leoni V; Biondi A
    Haematologica; 2015 Mar; 100(3):295-9. PubMed ID: 25740105
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current treatment of philadelphia chromosome-positive acute lymphoblastic leukemia].
    Sugiura I
    Rinsho Ketsueki; 2014 Oct; 55(10):1972-80. PubMed ID: 25297762
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylactic and preemptive therapy with dasatinib after hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Caocci G; Vacca A; Ledda A; Murgia F; Piras E; Greco M; Arras M; Atzeni S; Littera R; La Nasa G
    Biol Blood Marrow Transplant; 2012 Apr; 18(4):652-4. PubMed ID: 22240733
    [No Abstract]   [Full Text] [Related]  

  • 5. Current and future management of Ph/BCR-ABL positive ALL.
    Maino E; Sancetta R; Viero P; Imbergamo S; Scattolin AM; Vespignani M; Bassan R
    Expert Rev Anticancer Ther; 2014 Jun; 14(6):723-40. PubMed ID: 24611626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of acute lymphoblastic leukemia].
    Usui N
    Rinsho Ketsueki; 2008 Oct; 49(10):1374-85. PubMed ID: 18833922
    [No Abstract]   [Full Text] [Related]  

  • 7. High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group.
    Yanada M; Takeuchi J; Sugiura I; Akiyama H; Usui N; Yagasaki F; Kobayashi T; Ueda Y; Takeuchi M; Miyawaki S; Maruta A; Emi N; Miyazaki Y; Ohtake S; Jinnai I; Matsuo K; Naoe T; Ohno R;
    J Clin Oncol; 2006 Jan; 24(3):460-6. PubMed ID: 16344315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose increase of imatinib mesylate may overcome acquired resistance in bcr/abl-positive acute lymphoid leukaemia.
    Piccaluga PP; Malagola M; Rondoni M; Amabile M; Paolini S; Soverini S; Gaitani S; Visani G; Baccarani M; Martinelli G
    Eur J Haematol; 2004 Apr; 72(4):302-3. PubMed ID: 15089772
    [No Abstract]   [Full Text] [Related]  

  • 9. Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).
    Ottmann OG; Wassmann B; Pfeifer H; Giagounidis A; Stelljes M; Dührsen U; Schmalzing M; Wunderle L; Binckebanck A; Hoelzer D;
    Cancer; 2007 May; 109(10):2068-76. PubMed ID: 17429836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New approaches to the management of Philadelphia-chromosome-positive acute lymphocytic leukemia.
    Thomas DA; O'Brien S; Cortes J; Kantarjian H
    Curr Hematol Malig Rep; 2007 Jul; 2(3):183-9. PubMed ID: 20425368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute lymphoblastic leukemia in elderly: prognosis and treatment].
    Thomas X; Tavernier E; Le QH
    Bull Cancer; 2004 Sep; 91(9):713-20. PubMed ID: 15544997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of allogeneic haematopoietic stem cell transplantation in the outcome of Ph+ acute lymphoblastic leukaemia treated with an imatinib-containing regimen.
    Costa LJ
    Br J Haematol; 2009 Sep; 146(5):576-7. PubMed ID: 19555375
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lymphatic neoplasias in young patients].
    Borchmann P; Gökbuget N; Wulf G; Trümper L
    Onkologie; 2011; 34 Suppl 5():6-11. PubMed ID: 21921661
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
    Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M;
    Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment with imatinib-combined chemotherapy for relapsed Philadelphia-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation.
    IMAHASHI N; TOKUNAGA M; NISHIWAKI S; YANAGISAWA M; OZAWA Y; MIYAMURA K
    Rinsho Ketsueki; 2009 Nov; 50(11):1612-5. PubMed ID: 20009435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of adult acute lymphoblastic leukemia].
    Bernasconi C
    Haematologica; 1991 Jun; 76 Suppl 3():58-64. PubMed ID: 1752544
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination of imatinib and established antileukemic treatment modalities for otherwise refractory BCR-ABL positive lymphoblastic leukemia.
    Fruehauf S; Topaly J; Buss EC; Schad M; Goerner M; Zeller WJ; Ho AD
    Haematologica; 2002 Dec; 87(12):ECR38. PubMed ID: 12495909
    [No Abstract]   [Full Text] [Related]  

  • 18. Adult acute leukemia.
    Hoelzer D; Büchner T; Gale RP; Zittoun R
    Rev Invest Clin; 1994 Apr; Suppl():21-5. PubMed ID: 7886303
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 & ALL-3). The EORTC Leukemia Cooperative Study Group.
    Stryckmans P; De Witte T; Marie JP; Fillet G; Peetermans M; Bury J; Muus P; Andrien JM; Hayat M; Jaksic B
    Leukemia; 1992; 6 Suppl 2():199-203. PubMed ID: 1578934
    [No Abstract]   [Full Text] [Related]  

  • 20. High-risk acute lymphoblastic leukemia (ALL): is there an alternative approach for increasing the number of cures?
    Carella AM
    Haematologica; 1992; 77(4):348-51. PubMed ID: 1358772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.